These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35156939)

  • 1. Seroprevalence of SARS-CoV-2 antibodies among primary healthcare workers in the Republic of Srpska, Bosnia & Herzegovina: A cross-sectional study.
    Knežević D; Petković M; Božić L; Miljuš N; Mijović B; Aćimović J; Djaković-Dević J; Puhalo-Sladoje D; Mašić S; Spaić D; Todorović N; Pilipović-Broćeta N; Petrović V; Bokonjić D; Stojiljković MP; Škrbić R
    Acta Microbiol Immunol Hung; 2022 Feb; ():. PubMed ID: 35156939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 epidemiology, antibody dynamics, and neutralisation capacity in Irish healthcare workers in the era of booster COVID-19 vaccinations.
    McGrath J; Kenny C; Nielsen CS; Domegan L; Walsh C; Rooney P; Walsh S; Conlon N; Brady G; Ibrahim A; Dunne J; McCormack W; Corcoran N; Allen N; Fleming C; Bergin C
    Front Med (Lausanne); 2023; 10():1078022. PubMed ID: 36778745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of SARS-CoV-2 antibodies and knowledge, attitude and practice toward COVID-19 in the Republic of Srpska-Bosnia & Herzegovina: A population-based study.
    Mijović B; Mašić S; Petković M; Knežević D; Aćimović J; Djaković-Dević J; Puhalo-Sladoje D; Zeljković B; Spaić D; Bokonjić D; Škrbić R
    PLoS One; 2022; 17(1):e0262738. PubMed ID: 35089944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Antibodies to SARS-CoV-2 Following Natural Infection and Vaccination in Irish Hospital Healthcare Workers: Changing Epidemiology as the Pandemic Progresses.
    Allen N; Brady M; Ni Riain U; Conlon N; Domegan L; Carrion Martin AI; Walsh C; Doherty L; Higgins E; Kerr C; Bergin C; Fleming C
    Front Med (Lausanne); 2021; 8():758118. PubMed ID: 35186963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of SARS-CoV-2 antibodies in over 6000 healthcare workers in Spain.
    Varona JF; Madurga R; Peñalver F; Abarca E; Almirall C; Cruz M; Ramos E; Castellano Vázquez JM
    Int J Epidemiol; 2021 May; 50(2):400-409. PubMed ID: 33434269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare workers highly affected during the COVID-19 epidemic wave in Poland prior to vaccination availability: seroprevalence study.
    Rosińska M; Stępień M; Kitowska W; Milczarek M; Juszczyk G; Nowacka Z; Gardel A; Hermann A; Bardoń-Błaszkowska A; Cudnik R; Czubak H; Wolniak-Bińkowska M; Źródłowska IA; Sadkowska-Todys M
    Med Pr; 2022 Apr; 73(2):109-123. PubMed ID: 35301511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of seroprevalence to SARS-CoV-2 in blood donors in Sarajevo Canton, Federation of Bosnia and Herzegovina: Cross-sectional and longitudinal studies.
    Musa S; Catovic Baralija E; Ivey Sawin V; Nardone A; Palo M; Skocibusic S; Blazevic M; Cilovic Lagarija S; Ahmetovic-Karic G; Ljuca A; Dostovic-Halilovic S; Nedic R; Subissi L; Ibrahim R; Boshevska G; Bergeri I; Pebody R; Vaughan A
    Influenza Other Respir Viruses; 2023 Aug; 17(8):e13182. PubMed ID: 37621919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain.
    Peremiquel-Trillas P; Saura-Lázaro A; Benavente-Moreno Y; Casabonne D; Loureiro E; Cabrera S; Duran A; Garrote L; Brao I; Trelis J; Galán M; Soler F; Julià J; Cortasa D; Domínguez MÁ; Albasanz-Puig A; Gudiol C; Ramírez-Tarruella D; Muniesa J; Rivas JP; Muñoz-Montplet C; Sedano A; Plans À; Calvo-Cerrada B; Calle C; Clopés A; Carnicer-Pont D; Alemany L; Fernández E
    BMJ Open; 2022 Apr; 12(4):e056637. PubMed ID: 35450905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of SARS-CoV-2 antibodies in vaccinated healthcare workers in Marrakech (Morocco).
    Ben Houmich T; Tali A; Debbagh F; Lamrani Hanchi A; Soraa N
    Int J Immunopathol Pharmacol; 2022; 36():3946320221133697. PubMed ID: 36215392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High seroprevalence of SARS-CoV-2 antibodies in healthcare workers in COVID-19 wards indicates an occupational hazard-a prospective cohort study during the first year of the COVID-19 pandemic in Kalmar County, Sweden.
    Hultqvist V; Bonnedahl J; Edwardsson J; Tjernberg I; Rydén I
    APMIS; 2023 Sep; 131(9):491-497. PubMed ID: 37462243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and incidence of anti-SARS-CoV-2 antibodies among healthcare workers in Belgian hospitals before vaccination: a prospective cohort study.
    Mortgat L; Verdonck K; Hutse V; Thomas I; Barbezange C; Heyndrickx L; Fischer N; Vuylsteke B; Kabouche I; Ariën KK; Desombere I; Duysburgh E
    BMJ Open; 2021 Jun; 11(6):e050824. PubMed ID: 34187832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 antibody seroprevalence after the first wave among workers at a community healthcare system in the Greater Boston area.
    Bruno-Murtha LA; Osgood R; Lan FY; Buley J; Nathan N; Weiss M; MacDonald M; Kales SN; Sayah AJ
    Pathog Glob Health; 2021 Jul; 115(5):331-334. PubMed ID: 33729103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Acute Respiratory Syndrome Coronavirus-2 seroprevalence in South-Central Uganda, during 2019-2021.
    Ssuuna C; Galiwango RM; Kankaka EN; Kagaayi J; Ndyanabo A; Kigozi G; Nakigozi G; Lutalo T; Ssekubugu R; Wasswa JB; Mayinja A; Nakibuuka MC; Jamiru S; Oketch JB; Muwanga E; Chang LW; Grabowski MK; Wawer M; Gray R; Anderson M; Stec M; Cloherty G; Laeyendecker O; Reynolds SJ; Quinn TC; Serwadda D
    BMC Infect Dis; 2022 Feb; 22(1):174. PubMed ID: 35189840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study.
    Trieu MC; Bansal A; Madsen A; Zhou F; Sævik M; Vahokoski J; Brokstad KA; Krammer F; Tøndel C; Mohn KGI; Blomberg B; Langeland N; Cox RJ;
    J Infect Dis; 2021 Feb; 223(4):589-599. PubMed ID: 33247924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers.
    Gelanew T; Seyoum B; Mulu A; Mihret A; Abebe M; Wassie L; Gelaw B; Sorsa A; Merid Y; Muchie Y; Teklemariam Z; Tesfaye B; Osman M; Jebessa G; Atinafu A; Hailu T; Habte A; Kenea D; Gadisa A; Admasu D; Tesfaye E; Bates TA; Bulcha JT; Tschopp R; Tsehay D; Mullholand K; Howe R; Genetu A; Tafesse FG; Abdissa A
    BMC Infect Dis; 2022 Mar; 22(1):261. PubMed ID: 35296265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of SARS-CoV-2 antibodies among healthcare workers in a teaching hospital in Eastern India.
    Mishra B; Behera B; Singh AK; Mohapatra PR; Patro BK; Panigrahi MK; Pillai JSK; Barik S; Mahapatra A; Mohanty S; Hallur V; Gupta K; Batmanabane G
    J Family Med Prim Care; 2021 Aug; 10(8):2974-2979. PubMed ID: 34660434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study).
    Vokó Z; Kiss Z; Surján G; Surján O; Barcza Z; Wittmann I; Molnár GA; Nagy D; Müller V; Bogos K; Nagy P; Kenessey I; Wéber A; Polivka L; Pálosi M; Szlávik J; Rokszin G; Müller C; Szekanecz Z; Kásler M
    Front Immunol; 2022; 13():919408. PubMed ID: 35935993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RBD-specific antibody response after two doses of different SARS-CoV-2 vaccines during the mass vaccination campaign in Mongolia.
    Batmunkh B; Otgonbayar D; Shaarii S; Khaidav N; Shagdarsuren OE; Boldbaatar G; Danzan NE; Dashtseren M; Unurjargal T; Dashtseren I; Dagvasumberel M; Jagdagsuren D; Bayandorj O; Biziya B; Surenjid S; Togoo K; Bat-Erdene A; Narmandakh Z; Choijilsuren G; Batmunkh U; Soodoi C; Boldbaatar EA; Byambatsogt G; Byambaa O; Deleg Z; Enebish G; Chuluunbaatar B; Zulmunkh G; Tsolmon B; Gunchin B; Chimeddorj B; Dambadarjaa D; Sandag T
    PLoS One; 2023; 18(12):e0295167. PubMed ID: 38064430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 seroprevalence in healthcare workers in a high-volume ophthalmology centre in Guatemala.
    Davila-Siliezar P; Wer A; Barnoya J
    Ann Med; 2021 Dec; 53(1):1956-1959. PubMed ID: 34727801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative immunogenicity and safety of Gam-COVID-Vac and Sinopharm BBIBP-CorV vaccines: results of a pilot clinical study.
    Stoma I; Korsak K; Voropaev E; Osipkina O; Kovalev A
    Heliyon; 2023 Nov; 9(11):e21877. PubMed ID: 38027828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.